Sterility Indicators Market Trends

  • Report ID: 6750
  • Published Date: Nov 28, 2024
  • Report Format: PDF, PPT

Sterility Indicators Market Trends

Growth Drivers

  • Increasing healthcare needs and infection control: The growing number of surgeries and invasive medical procedures necessitates strict infection control measures. Sterility indicators play a critical role in ensuring that sterilization processes for surgical instruments and equipment are effective, reducing the risk of postoperative infections. HAIs pose a major challenge to healthcare systems worldwide. According to WHO, HAIs typically impact 1 out of 10 patients; however, in low- and middle-income nations and among high-risk patients, such as those in intensive care units, the frequency can be significantly greater.
    The COVID-19 pandemic underscored the importance of infection prevention and control, leading to heightened awareness and adoption of sterilization protocols. This has significantly boosted the sterility indicators market as healthcare facilities prioritize effective sterilization.
  • Rise in infectious diseases: Global health agencies report a surge in diseases such as tuberculosis (TB), influenza, and emerging viral infections. According to the Centers for Disease Control and Prevention (CDC), in 2023, the 50 U.S. states and the District of Columbia provisionally reported 9,615 tuberculosis cases, up 1,295 cases (16%) from 8,320 cases reported in 2022 and up 8% from the 2019 prepandemic case count (8,895). Overall, the U.S. tuberculosis rate rose by 15%, from 2.5 per 100,000 people in 2022 to 2.9 by 2023.

    In regions with limited access to healthcare, infectious diseases remain a major concern. Increased awareness and investment in healthcare infrastructure in areas like the Asia Pacific are driving demand for sterility solutions, including indicators.
  • Growth in healthcare infrastructure: Developing countries are heavily investing in building hospitals, clinics, and diagnostic labs. This expansion requires robust infection control solutions, driving the adoption of sterility indicators to ensure safety and compliance. Enhanced infrastructure supports a higher volume of surgical procedures and diagnostic tests, which depend on sterile environments. Sterility indicators ensure the effective sterilization of instruments and devices used in these processes, fostering sterility indicators market growth.

    Modernized facilities adopt advanced medical technologies and equipment requiring rigorous sterilization. Sterility indicators are integral to monitoring and validating these processes, ensuring compliance with stringent healthcare regulations.

Challenges

  • High cost of advanced sterility indicators: Advanced sterility indicators, such as rapid biological indicators and automated systems with traceability features, are costly to manufacture and purchase. These costs can be prohibitive for smaller healthcare facilities or organizations in low-income regions. Healthcare facilities in developing countries often operate under tight budgets, prioritizing essential equipment over sterility monitoring tools. This limits the adoption of high-end sterility indicators, despite their effectiveness in ensuring safety.
  • Growing adoption of alternative sterilization methods: Chemical sterilants, such as ethylene oxide (EtO), hydrogen peroxide, and peracetic acid, are gaining popularity due to their ability to sterilize heat-sensitive instruments. These methods often include integrated sterilization validation processes, reducing reliance on separate sterility indicators.

Sterility Indicators Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

10.1%

Base Year Market Size (2024)

USD 1.13 billion

Forecast Year Market Size (2037)

USD 3.93 billion

Regional Scope

  • North America (U.S., and Canada) 
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia-Pacific) 
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) 
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America) 
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa) 

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6750
  • Published Date: Nov 28, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The global sterility indicators market registered a valuation of USD 1.13 billion in 2024 and is poised to expand at a CAGR of 10.1% during the forecast period, i.e., 2025-2037.

The global sterility indicators sector registered a profitable valuation of USD 1.13 billion in 2024 and is poised to register USD 3.93 billion in 2037 expanding at a CAGR of 10.1% during the forecast period, i.e., 2025-2037.

The major players in the market are 3M, Cardinal Health, MATACHANA group, Mesa Labs, Inc., Andersen Sterilizers, PMS Healthcare Technologies, and others.

By type, the biological indicators segment is poised to register the largest revenue share of 68.6% by 2037. The market growth is driven by biological indicators’ unmatched accuracy, regulatory backing, and technological innovations

North America is poised to register the largest revenue share of 52.9% by the end of 2037. The market growth can be attributed to the region’s advanced healthcare infrastructure, a rising prevalence of hospital-acquired infections, and stringent regulatory requirements for sterilization in healthcare facilities and pharmaceutical production.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample